Galvokimig

(Synonyms: UCB-9741)
Customer Review

Based on 1 Customer Validation

Galvokimig (UCB-9741) is an anti-IL-13/IL-17A/albumin (ALB)/IL-17F trispecific Fab-scFv fusion protein. Galvokimig simultaneously binds IL-13 and IL-17 with high affinity and has an extended half-life through albumin binding. Galvokimig inhibits IL-13-mediated, IL-17A-mediated, and IL-17F-mediated signaling. Galvokimig inhibits IL-17A- and IL-17F-induced IL-6 release in dermal fibroblasts and inhibits IL-19 and IL-24 production in primary epidermal keratinocytes. Galvokimig can be used for research on atopic dermatitis.

For research use only. We do not sell to patients.

  • Purity : 99.71%
  • CAS No.: 2648456-30-6
  • Molecular Weight:101.953 kDa
  • Storage:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00